Cargando…
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
Type II endometrial carcinomas are a highly aggressive group of tumour subtypes that are frequently associated with inactivation of the TP53 tumour suppressor gene. We show that mice with endometrium-specific deletion of Trp53 initially exhibited histological changes that are identical to known prec...
Autores principales: | Wild, Peter J, Ikenberg, Kristian, Fuchs, Thomas J, Rechsteiner, Markus, Georgiev, Strahil, Fankhauser, Niklaus, Noske, Aurelia, Roessle, Matthias, Caduff, Rosmarie, Dellas, Athanassios, Fink, Daniel, Moch, Holger, Krek, Wilhelm, Frew, Ian J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494078/ https://www.ncbi.nlm.nih.gov/pubmed/22678923 http://dx.doi.org/10.1002/emmm.201101063 |
Ejemplares similares
-
Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing – a case report
por: Valtcheva, Nadejda, et al.
Publicado: (2017) -
Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro
por: Koppensteiner, Romana, et al.
Publicado: (2014) -
Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
por: Albers, Joachim, et al.
Publicado: (2013) -
Identification of a Gene Expression Signature Common to Distinct Cancer Pathways
por: Fankhauser, Niklaus, et al.
Publicado: (2012) -
Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer
por: Noske, Aurelia, et al.
Publicado: (2016)